查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684772

心肺机市场机会、成长动力、产业趋势分析和 2025 - 2034 年预测

Heart-lung Machine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球心肺机市场价值为 3.698 亿美元，并将大幅扩张，预计 2025 年至 2034 年的年复合成长率(CAGR) 为 4.6%。随着心血管疾病的增加和器官移植手术的增加，心肺机的需求激增。这些机器在复杂的外科手术过程中提供生命维持至关重要，例如心臟手术和器官移植，稳定的血液循环和氧合至关重要。它们在提高患者存活率和改善治疗效果方面发挥的作用正在推动医院、诊所和其他医疗机构的广泛采用。心肺机的技术创新，包括更有效率、更用户友善的系统，也在推动市场成长。随着全球医疗保健系统的现代化和扩大获得先进治疗的机会，对可靠和高性能心肺机的需求变得越来越重要。

心肺机市场 - IMG1

市场主要分为两大类：单滚轮泵浦系统和双滚轮泵浦系统。单滚轮泵浦市场预计将占据主导地位，年复合成长率为 4.3%，到 2034 年将达到 3.37 亿美元。这些帮浦以其在手术期间提供稳定血流的可靠性而闻名，这对于维持稳定的体外膜氧合 (ECMO) 至关重要。它们设计简单且经济高效，成为医院和医疗机构的热门选择，尤其是在经常需要精打细算的解决方案的新兴市场。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 3.698 亿美元
预测值 5.759 亿美元
复合年增长率 4.6％

从应用方面来看，心肺机主要用于医院和诊所、门诊手术中心和其他医疗机构。医院和诊所部门预计将稳定成长，到 2034 年将达到 2.414 亿美元。这些机器在重症监护中发挥关键作用，特别是在移植后过程中，它们有助于稳定患者病情并降低器官排斥的风险。它们在支持免疫抑制疗法方面的有效性进一步巩固了它们在世界各地医院和诊所中的重要地位。

光是在美国，2024 年心肺机市场价值就达到 1.396 亿美元，预计到 2034 年复合年增长率将达到 3.9%。这一增长是由大量心臟手术推动的，例如冠状动脉绕道术 (CABG) 和瓣膜置换术，这些手术需要可靠的心肺机支持。强大的医疗保健基础设施、优惠的报销政策以及持续的研发投资等因素继续使美国在全球市场占据领先地位。随着心血管疾病发病率的不断上升，美国对心肺机的需求预计将上升，确保这一关键市场继续成长。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 心血管疾病发生率不断上升
      • 器官移植手术数量不断增加
      • 心肺机的技术进步
    • 产业陷阱与挑战
      • 先进心肺机价格昂贵
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 报销场景
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未来市场趋势

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2034 年

  • 主要趋势
  • 单滚轮泵
  • 双滚轮泵

第 6 章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 心臟手术
  • 肺部手术
  • 急性呼吸衰竭治疗
  • 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2034 年

  • 主要趋势
  • 医院和诊所
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第九章：公司简介

  • BRAILE
  • Edwards
  • ELITE LIFE CARE
  • EUROSETS
  • FRESENIUS MEDICAL CARE
  • GETINGE
  • HEART CARE INDIA CO
  • hemovent
  • Jarvik HEART
  • LivaNova
  • Medtronic
  • NIPRO
  • Palex
  • Philips
  • TERUMO
简介目录
Product Code: 6060

The Global Heart-Lung Machine Market, valued at USD 369.8 million in 2024, is set to expand significantly, with an expected compound annual growth rate (CAGR) of 4.6% from 2025 to 2034. As cardiovascular diseases rise and organ transplant surgeries increase, the demand for heart-lung machines has surged. These machines are crucial in providing life support during complex surgical procedures, such as cardiac surgeries and organ transplants, where stable blood circulation and oxygenation are vital. Their role in enhancing patient survival rates and improving outcomes is driving widespread adoption across hospitals, clinics, and other healthcare facilities. Technological innovations in heart-lung machines, including more efficient and user-friendly systems, are also propelling market growth. As healthcare systems globally modernize and expand access to advanced treatments, the need for reliable and high-performing heart-lung machines becomes increasingly important.

Heart-lung Machine Market - IMG1

The market is divided into two main categories: single-roller pump systems and double-roller pump systems. The single-roller pump segment is expected to dominate, growing at a CAGR of 4.3% and reaching USD 337 million by 2034. These pumps are known for their reliability in providing consistent blood flow during surgeries, which is essential for maintaining stable extracorporeal membrane oxygenation (ECMO). Their simple design and cost-effectiveness make them a popular choice in hospitals and healthcare facilities, especially in emerging markets where budget-conscious solutions are often required.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$369.8 Million
Forecast Value$575.9 Million
CAGR4.6%

In terms of application, heart-lung machines are primarily used in hospitals and clinics, ambulatory surgical centers, and other medical institutions. The hospitals and clinics segment is anticipated to grow steadily, reaching USD 241.4 million by 2034. These machines play a key role in critical care, especially during post-transplantation procedures, where they help stabilize patients and reduce the risk of organ rejection. Their effectiveness in supporting immunosuppressive therapies further reinforces their essential presence in hospitals and clinics worldwide.

In the U.S. alone, the heart-lung machine market was valued at USD 139.6 million in 2024 and is projected to grow at a CAGR of 3.9% through 2034. This growth is driven by the high volume of cardiac surgeries, such as coronary artery bypass grafting (CABG) and valve replacements, which require reliable heart-lung machine support. Factors like a strong healthcare infrastructure, favorable reimbursement policies, and ongoing investments in research and development continue to position the U.S. as a leader in the global market. With the increasing incidence of cardiovascular diseases, the demand for heart-lung machines in the U.S. is expected to rise, ensuring the continued growth of this critical market.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular disease
      • 3.2.1.2 Growing number of organ transplant surgeries
      • 3.2.1.3 Technological advancements in heart-lung machines
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced heart-lung machines
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Single roller pump
  • 5.3 Double roller pump

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiac surgeries
  • 6.3 Lung surgeries
  • 6.4 Acute respiratory failure treatment
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals and clinics
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 BRAILE
  • 9.2 Edwards
  • 9.3 ELITE LIFE CARE
  • 9.4 EUROSETS
  • 9.5 FRESENIUS MEDICAL CARE
  • 9.6 GETINGE
  • 9.7 HEART CARE INDIA CO
  • 9.8 hemovent
  • 9.9 Jarvik HEART
  • 9.10 LivaNova
  • 9.11 Medtronic
  • 9.12 NIPRO
  • 9.13 Palex
  • 9.14 Philips
  • 9.15 TERUMO